SwitchPoint Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
348
+7
+2% +$7.15K 0.24% 48
2026
Q1
$314K Buy
341
+1
+0.3% +$1.01K 0.21% 49
2025
Q4
$366K Buy
340
+26
+8% +$24.9K 0.26% 44
2025
Q3
$240K Buy
314
+7
+2% +$5.21K 0.17% 55
2025
Q2
$240K Buy
+307
New +$239K 0.2% 52

Other funds holding LLY

SwitchPoint Financial Planning's LLY Position: Q2 2026 in Review

SwitchPoint Financial Planning increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $7.15K and bringing the position to 348 shares worth $418K. The position accounts for 0.24% of the portfolio, ranked #48.

SwitchPoint Financial Planning first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SwitchPoint Financial Planning held 348 shares of Eli Lilly worth $418K as of Q2 2026.
  • SwitchPoint Financial Planning bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.24% of SwitchPoint Financial Planning's portfolio in Q2 2026, its #48 holding.
  • SwitchPoint Financial Planning first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SwitchPoint Financial Planning's 13F filing for Q2 2026, filed 17 Aug 2026.